PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,125 | -52.7% | 2,713 | -36.2% | 0.00% | – |
| Q2 2023 | $59,408 | +5410.9% | 4,251 | +2715.2% | 0.00% | – |
| Q1 2023 | $1,078 | -46.1% | 151 | +0.7% | 0.00% | – |
| Q4 2022 | $2,000 | -66.7% | 150 | -72.7% | 0.00% | – |
| Q3 2022 | $6,000 | -94.3% | 550 | -95.6% | 0.00% | – |
| Q2 2022 | $106,000 | -83.9% | 12,561 | -74.1% | 0.00% | -100.0% |
| Q1 2022 | $659,000 | +488.4% | 48,415 | +754.2% | 0.00% | – |
| Q4 2021 | $112,000 | +67.2% | 5,668 | +173.0% | 0.00% | – |
| Q3 2021 | $67,000 | +63.4% | 2,076 | +69.7% | 0.00% | – |
| Q2 2021 | $41,000 | -10.9% | 1,223 | 0.0% | 0.00% | – |
| Q1 2021 | $46,000 | +12.2% | 1,223 | 0.0% | 0.00% | – |
| Q4 2020 | $41,000 | -8.9% | 1,223 | 0.0% | 0.00% | – |
| Q3 2020 | $45,000 | +80.0% | 1,223 | +63.1% | 0.00% | – |
| Q2 2020 | $25,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |